|
There may be a difference between normal breast tissue in women
at high risk of developing breast cancer and women who are at
normal risk, according to Cancer Research Campaign researchers.
Investigators
have compared normal breast tissue from women with the BRCA gene
mutation, a risk factor for breast cancer, with breast tissue
from women at normal risk and found crucial differences.
The primary
difference appears to be in the way the cells respond to estrogen
as well as estrogen-suppressing drugs such as Tamoxifen.
"When
we added estrogen to the breast tissue, we expected a bigger response
from the BRCA cells," said Dr. Rob Clarke of the Paterson
Institute for Cancer Research in Manchester, England and lead
researcher. "We thought they would grow faster than the normal
cells but this didn't happen. Instead we found a far more subtle
difference in the way other genes were responding to estrogen."
Researchers
are hopeful that understanding these differences may lead to better
drugs to fight breast cancer.
Other
Sources: Cancer Research Campaign
|